Science
Science
Redwire and EnduroSat Sign MOU to Strengthen European Space Infrastructure
Redwire Corporation (NYSE: RDW), a global leader in space and defence technology solutions, and EnduroSat, a space company building standardized, software-flexible satellites and a streamlined constellations-as-a-service…
October 21, 2026 · 7:00 AM
Science|Compvide
Compvide Announces Commercial Launch of CIMED and Presents New Research at European Meeting on Complement in Human Disease (EMCHD) 2026
Compvide, Inc. today announced the commercial launch of its CIMED platform. The CIMED-AP, CIMED-LP, and CIMED-CP kits assess the alternative, lectin, and classical complement pathways, respectively, using 50% serum to su…
October 21, 2026 · 6:47 AM
Science
Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) to evaluate ivonescimab, a novel, potential first-in-class investigational bis…
October 21, 2026 · 6:05 AM
Science|Thermo Fisher Scientific
Thermo Fisher Scientific Reports Third Quarter 2026 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2026. Third Quarter Highlights Third quarter revenue grew 9%…
October 21, 2026 · 6:00 AM
Science
Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that two oral presentations and two poster presentations featuring its NeXT Personal ultrasensitive circulating tumor…
October 21, 2026 · 6:00 AM
Science
Syntax Bio Programs Stem Cells Toward Pancreatic Beta Cells in Four Days
Syntax Bio presents data showing its Cellgorithm platform programs stem cells toward pancreatic beta cells in four days....
October 21, 2026 · 5:00 AM
Science|Okomera
Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research
Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the signing of a commercial ag…
October 21, 2026 · 2:00 AM
Science
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
Innate Pharma to participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference...
October 21, 2026 · 1:00 AM
Science|Department of Health – Abu Dhabi and ŌURA
Department of Health – Abu Dhabi and ŌURA Launch Research Partnership to Study Early Warning Signs of Premature Birth
Project CRADLE is a first-of-its-kind 24-month pilot study examining whether continuous wearable data can help predict spontaneous premature birth....
October 20, 2026 · 11:00 PMScience
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B (CHB) virus infection in combination with nucleos(t)ide…
October 20, 2026 · 7:58 PMLatest from leading organizations
Explore recent announcements by organization
